Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oncogene mutation and prognosis in the myelodysplastic syndromes.

British journal of haematology - 1 Dec 2000

Padua R A, West R R

Abstract excerpt

In a series of myelodysplastic syndrome patients, mutational status (particularly RAS mutation) was found to be prognostic for survival, independently of four previously reported scoring systems (Bournemouth, Sanz, Lille, International).

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Anemia, Sideroblastic
Share to Genes, p53

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, ras

Share to Leukemia, Myelomonocytic, Chronic

Share to Myelodysplastic Syndromes

Share to Predictive Value of Tests

Share to Proportional Hazards Models

Source

Identifiers

PMID: 11122149

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Oncogene mutation and prognosis in the myelodysplastic syndromes.PMID 11122149Read ↗

Prognostic impact of RAS-pathway mutations in patients with myelofibrosisSemantic proximity Read ↗

Oncogenes and growth factor genes in myelodysplasia.Semantic proximity Read ↗

The role of ras gene mutations in myeloproliferative disorders.Semantic proximity Read ↗

Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.Semantic proximity Read ↗

RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up.Semantic proximity Read ↗

N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome.Semantic proximity Read ↗

Ras oncogene mutations and survival in patients with lung cancer.Semantic proximity Read ↗

International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.